Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Molecular signatures of increased freezing tolerance due to low temperature memory in Arabidopsis.

Zuther E, Schaarschmidt S, Fischer A, Erban A, Pagter M, Mubeen U, Giavalisco P, Kopka J, Sprenger H, Hincha DK.

Plant Cell Environ. 2018 Dec 12. doi: 10.1111/pce.13502. [Epub ahead of print]

PMID:
30548618
2.

Food Perception Primes Hepatic ER Homeostasis via Melanocortin-Dependent Control of mTOR Activation.

Brandt C, Nolte H, Henschke S, Engström Ruud L, Awazawa M, Morgan DA, Gabel P, Sprenger HG, Hess ME, Günther S, Langer T, Rahmouni K, Fenselau H, Krüger M, Brüning JC.

Cell. 2018 Nov 15;175(5):1321-1335.e20. doi: 10.1016/j.cell.2018.10.015.

PMID:
30445039
3.

Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy.

Sprenger HG, Wani G, Hesseling A, König T, Patron M, MacVicar T, Ahola S, Wai T, Barth E, Rugarli EI, Bergami M, Langer T.

EMBO Mol Med. 2018 Nov 2. pii: e9288. doi: 10.15252/emmm.201809288. [Epub ahead of print]

4.

Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.

Mittenbühler MJ, Sprenger HG, Gruber S, Wunderlich CM, Kern L, Brüning JC, Wunderlich FT.

Mol Metab. 2018 Nov;17:122-133. doi: 10.1016/j.molmet.2018.08.010. Epub 2018 Sep 5.

5.

m-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration.

Patron M, Sprenger HG, Langer T.

Cell Res. 2018 Mar;28(3):296-306. doi: 10.1038/cr.2018.17. Epub 2018 Feb 16. Review.

6.

Fic Proteins of Campylobacter fetus subsp. venerealis Form a Network of Functional Toxin-Antitoxin Systems.

Sprenger H, Kienesberger S, Pertschy B, Pöltl L, Konrad B, Bhutada P, Vorkapic D, Atzmüller D, Feist F, Högenauer C, Gorkiewicz G, Zechner EL.

Front Microbiol. 2017 Oct 17;8:1965. doi: 10.3389/fmicb.2017.01965. eCollection 2017.

7.

Metabolite and transcript markers for the prediction of potato drought tolerance.

Sprenger H, Erban A, Seddig S, Rudack K, Thalhammer A, Le MQ, Walther D, Zuther E, Köhl KI, Kopka J, Hincha DK.

Plant Biotechnol J. 2018 Apr;16(4):939-950. doi: 10.1111/pbi.12840. Epub 2017 Oct 17.

8.

Helicopter thermal imaging for detecting insect infested cadavers.

Amendt J, Rodner S, Schuch CP, Sprenger H, Weidlich L, Reckel F.

Sci Justice. 2017 Sep;57(5):366-372. doi: 10.1016/j.scijus.2017.04.008. Epub 2017 Apr 20.

PMID:
28889866
9.

Yield of yearly routine physical examination in HIV-1 infected patients is limited: A retrospective cohort study in the Netherlands.

van Amsterdam MA, van Assen S, Sprenger HG, Wilting KR, Stienstra Y, Bierman WFW.

PLoS One. 2017 Jun 21;12(6):e0179539. doi: 10.1371/journal.pone.0179539. eCollection 2017.

10.

Detection and volume estimation of artificial hematomas in the subcutaneous fatty tissue: comparison of different MR sequences at 3.0 T.

Ogris K, Petrovic A, Scheicher S, Sprenger H, Urschler M, Hassler EM, Yen K, Scheurer E.

Forensic Sci Med Pathol. 2017 Jun;13(2):135-144. doi: 10.1007/s12024-017-9847-8. Epub 2017 Mar 1.

11.

Temperature dependence of viscosity, relaxation times (T1, T2) and simulated contrast for potential perfusates in post-mortem MR angiography (PMMRA).

Webb B, Widek T, Neumayer B, Bruguier C, Scheicher S, Sprenger H, Grabherr S, Schwark T, Stollberger R.

Int J Legal Med. 2017 May;131(3):739-749. doi: 10.1007/s00414-016-1482-5. Epub 2016 Nov 29.

12.

Time-Dependent Changes in T1 during Fracture Healing in Juvenile Rats: A Quantitative MR Approach.

Baron K, Neumayer B, Amerstorfer E, Scheurer E, Diwoky C, Stollberger R, Sprenger H, Weinberg AM.

PLoS One. 2016 Nov 10;11(11):e0164284. doi: 10.1371/journal.pone.0164284. eCollection 2016.

13.

Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events.

Sprenger HG, Bierman WF, Martes MI, Graaff R, van der Werf TS, Smit AJ.

AIDS. 2017 Jan 14;31(2):241-246. doi: 10.1097/QAD.0000000000001297.

PMID:
27763891
14.

The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i-AAA protease YME1L.

Wai T, Saita S, Nolte H, Müller S, König T, Richter-Dennerlein R, Sprenger HG, Madrenas J, Mühlmeister M, Brandt U, Krüger M, Langer T.

EMBO Rep. 2016 Dec;17(12):1844-1856. Epub 2016 Oct 13.

15.

The drought response of potato reference cultivars with contrasting tolerance.

Sprenger H, Kurowsky C, Horn R, Erban A, Seddig S, Rudack K, Fischer A, Walther D, Zuther E, Köhl K, Hincha DK, Kopka J.

Plant Cell Environ. 2016 Nov;39(11):2370-2389. doi: 10.1111/pce.12780. Epub 2016 Sep 6.

PMID:
27341794
16.

Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria.

Korwitz A, Merkwirth C, Richter-Dennerlein R, Tröder SE, Sprenger HG, Quirós PM, López-Otín C, Rugarli EI, Langer T.

J Cell Biol. 2016 Jan 18;212(2):157-66. doi: 10.1083/jcb.201507022.

17.

TB-HIV co-infection in the Netherlands: estimating prevalence and under-reporting in national registration databases using a capture-recapture analysis.

van Leth F, Evenblij K, Wit F, Kiers A, Sprenger H, Verhagen M, Hillebregt M, Kalisvaart N, Schimmel H, Verbon A.

J Epidemiol Community Health. 2016 Jun;70(6):556-60. doi: 10.1136/jech-2015-206680. Epub 2015 Dec 23.

PMID:
26700301
18.

Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous Dysplasia.

Gray MJ, Kannu P, Sharma S, Neyt C, Zhang D, Paria N, Daniel PB, Whetstone H, Sprenger HG, Hammerschmidt P, Weng A, Dupuis L, Jobling R, Mendoza-Londono R, Dray M, Su P, Wilson MJ, Kapur RP, McCarthy EF, Alman BA, Howard A, Somers GR, Marshall CR, Manners S, Flanagan AM, Rathjen KE, Karol LA, Crawford H, Markie DM, Rios JJ, Wise CA, Robertson SP.

Am J Hum Genet. 2015 Dec 3;97(6):837-47. doi: 10.1016/j.ajhg.2015.11.001.

19.

Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207.

Hitti J, Halvas EK, Zheng L, Panousis CG, Kabanda J, Taulo F, Kumarasamy N, Pape JW, Lalloo U, Sprenger H, Klingman KL, Chan ES, McMahon D, Mellors JW.

J AIDS Clin Res. 2014 Nov;5(11). pii: 371. Epub 2014 Nov 9.

20.

The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases.

Zollner-Schwetz I, Herzog KA, Feierl G, Leitner E, Schneditz G, Sprenger H, Prattes J, Petritsch W, Wenzl H, Kump P, Gorkiewicz G, Zechner E, Högenauer C.

Dig Dis Sci. 2015 Nov;60(11):3393-8. doi: 10.1007/s10620-015-3765-y. Epub 2015 Jun 20.

PMID:
26091802
21.

A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study.

Sprenger HG, Langebeek N, Mulder PG, Ten Napel CH, Vriesendorp R, Hoepelman AI, Legrand JC, Koopmans PP, Bravenboer B, Ten Kate RW, Groeneveld P, Bierman W, van der Werf Ts, Gisolf E, Richter C.

HIV Med. 2015 Feb;16(2):122-31. doi: 10.1111/hiv.12186. Epub 2014 Dec 4.

22.

Maintaining hydration with a carbohydrate-electrolyte solution improves performance, thermoregulation, and fatigue during an ice hockey scrimmage.

Linseman ME, Palmer MS, Sprenger HM, Spriet LL.

Appl Physiol Nutr Metab. 2014 Nov;39(11):1214-21. doi: 10.1139/apnm-2014-0091. Epub 2014 May 28.

PMID:
25061764
23.

A systematic review of a single-class maintenance strategy with nucleoside/nucleotide reverse transcriptase inhibitors in HIV/AIDS.

Sprenger HG, Bierman WF, van der Werf TS, Gisolf EH, Richter C.

Antivir Ther. 2014;19(7):625-36. doi: 10.3851/IMP2726. Epub 2014 Jan 16. Review.

PMID:
24429420
24.

Comparative genome analysis of Campylobacter fetus subspecies revealed horizontally acquired genetic elements important for virulence and niche specificity.

Kienesberger S, Sprenger H, Wolfgruber S, Halwachs B, Thallinger GG, Perez-Perez GI, Blaser MJ, Zechner EL, Gorkiewicz G.

PLoS One. 2014 Jan 9;9(1):e85491. doi: 10.1371/journal.pone.0085491. eCollection 2014.

25.

A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial.

Langebeek N, Sprenger HG, Gisolf EH, Reiss P, Sprangers MA, Legrand J, Richter C, Nieuwkerk PT.

HIV Med. 2014 May;15(5):286-90. doi: 10.1111/hiv.12112. Epub 2013 Nov 11.

26.

Conducting molecular biomarker discovery studies in plants.

Schudoma C, Steinfath M, Sprenger H, van Dongen JT, Hincha D, Zuther E, Geigenberger P, Kopka J, Köhl K, Walther D.

Methods Mol Biol. 2012;918:127-50. doi: 10.1007/978-1-61779-995-2_10. Review.

PMID:
22893290
27.

So close and yet so far - Molecular Microbiology of Campylobacter fetus subspecies.

Sprenger H, Zechner EL, Gorkiewicz G.

Eur J Microbiol Immunol (Bp). 2012 Mar;2(1):66-75. doi: 10.1556/EuJMI.2.2012.1.10. Epub 2012 Mar 17. Review.

28.

Fever and persisting cough. Amoebic liver abscess.

Wilting KR, Kampinga GA, van Leeuwen JT, Slart RH, Sprenger HG.

Neth J Med. 2011 Oct;69(10):454, 464. No abstract available.

29.

Pegylated interferon-α monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C.

Arends JE, van Assen S, Stek CJ, Wensing AM, Fransen JH, Schellens IM, Spijkers SN, Mudrikova T, van Baarle D, Sprenger HG, Hoepelman AI.

Antivir Ther. 2011;16(7):979-88. doi: 10.3851/IMP1843.

PMID:
22024513
30.

Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates.

Baatz F, Nijhuis M, Lemaire M, Riedijk M, Wensing AM, Servais JY, van Ham PM, Hoepelman AI, Koopmans PP, Sprenger HG, Devaux C, Schmit JC, Perez Bercoff D.

PLoS One. 2011;6(7):e21535. doi: 10.1371/journal.pone.0021535. Epub 2011 Jul 8.

31.

Active cytomegalovirus infection in patients with acute venous thrombosis: a case-control study.

Tichelaar VY, Sprenger HG, Mäkelburg AB, Niesters BG, Kluin-Nelemans HC, Lijfering WM.

Am J Hematol. 2011 Jun;86(6):510-2. doi: 10.1002/ajh.22006. Epub 2011 Apr 20. No abstract available.

32.

Relationship between cytomegalovirus infection and procoagulant changes in human immunodeficiency virus-infected patients.

Mulder R, Tichelaar YI, Sprenger HG, Mulder AB, Lijfering WM.

Clin Microbiol Infect. 2011 May;17(5):747-9. doi: 10.1111/j.1469-0691.2010.03415.x.

33.

Interbacterial macromolecular transfer by the Campylobacter fetus subsp. venerealis type IV secretion system.

Kienesberger S, Schober Trummler C, Fauster A, Lang S, Sprenger H, Gorkiewicz G, Zechner EL.

J Bacteriol. 2011 Feb;193(3):744-58. doi: 10.1128/JB.00798-10. Epub 2010 Nov 29.

34.

Unusual cluster of HIV type 1 dual infections in Groningen, The Netherlands.

van der Kuyl AC, Jurriaans S, Back NK, Sprenger HG, van der Werf TS, Zorgdrager F, Berkhout B, Cornelissen M.

AIDS Res Hum Retroviruses. 2011 Apr;27(4):429-33. doi: 10.1089/aid.2010.0175. Epub 2010 Nov 18.

PMID:
21087141
35.

Two donor-related infections in a heart transplant recipient: one common, the other a tropical surprise.

Brügemann J, Kampinga GA, Riezebos-Brilman A, Stek CJ, Edel JP, van der Bij W, Sprenger HG, Zijlstra F.

J Heart Lung Transplant. 2010 Dec;29(12):1433-7. doi: 10.1016/j.healun.2010.08.002. Review.

PMID:
20888254
36.

Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands.

Kesselring AM, Gras L, Wit FW, Smit C, Geerlings SE, Mulder JW, Schreij G, Sprenger HG, Reiss P, de Wolf F.

Antivir Ther. 2010;15(6):871-9. doi: 10.3851/IMP1638.

PMID:
20834099
37.

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.

Stellbrink HJ, Orkin C, Arribas JR, Compston J, Gerstoft J, Van Wijngaerden E, Lazzarin A, Rizzardini G, Sprenger HG, Lambert J, Sture G, Leather D, Hughes S, Zucchi P, Pearce H; ASSERT Study Group.

Clin Infect Dis. 2010 Oct 15;51(8):963-72. doi: 10.1086/656417.

PMID:
20828304
38.

Neuralgic amyotrophy associated with Bartonella henselae infection.

Stek CJ, van Eijk JJ, Jacobs BC, Enting RH, Sprenger HG, van Alfen N, van Assen S.

J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):707-8. doi: 10.1136/jnnp.2009.191940. Epub 2010 Aug 14. No abstract available.

PMID:
20710009
39.

Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.

Overton ET, Kang M, Peters MG, Umbleja T, Alston-Smith BL, Bastow B, Demarco-Shaw D, Koziel MJ, Mong-Kryspin L, Sprenger HL, Yu JY, Aberg JA.

Vaccine. 2010 Aug 2;28(34):5597-604. doi: 10.1016/j.vaccine.2010.06.030. Epub 2010 Jun 23.

40.

Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: FREE randomized trial interim results.

Sprenger HG, Langebeek N, Mulder PG, Ten Napel CH, Vriesendorp R, Hoepelman AI, Legrand JC, Koopmans PP, Van Kasteren ME, Bravenboer B, Ten Kate RW, Groeneveld PH, van der Werf TS, Gisolf EH, Richter C.

AIDS Patient Care STDS. 2010 Jun;24(6):361-6. doi: 10.1089/apc.2009.0236.

PMID:
20515418
41.

[Drug interaction caused by communication problems. Rhabdomyolysis due to a combination of itraconazole and simvastatin].

Tiessen RG, Lagerwey HJ, Jager GJ, Sprenger HG.

Ned Tijdschr Geneeskd. 2010;154:A762. Dutch.

PMID:
20456775
42.

Beneath the surface.

Martens HA, Koornstra JJ, Diepstra A, Sprenger HG, Kallenberg CG.

Am J Med. 2009 Feb;122(2):132-4. doi: 10.1016/j.amjmed.2008.10.023. No abstract available.

PMID:
19185087
43.

Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults.

Sleasman JW, Robbins BL, Cross SJ, Lindsey JC, Kraimer JM, Heckman BE, Sprenger HL, Tustin NB, Rose CH, Poston PA, Neal EF, Pakes GE, Nikanjam M, Capparelli EV.

Clin Pharmacol Ther. 2009 Apr;85(4):394-401. doi: 10.1038/clpt.2008.236. Epub 2008 Dec 31.

44.

Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection.

Lijfering WM, Sprenger HG, Georg RR, van der Meulen PA, van der Meer J.

Clin Chem. 2008 Jul;54(7):1226-33. doi: 10.1373/clinchem.2008.103614. Epub 2008 May 1.

45.

Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia.

Meeuse JJ, Sprenger HG, van Assen S, Leduc D, Daenen SM, Arends JP, van der Werf TS.

Emerg Infect Dis. 2007 Dec;13(12):1942-3. doi: 10.3201/eid1312.061559.

46.

Venous thromboembolism in HIV-positive women during puerperium: a case series.

Jansen JM, Lijfering WM, Sprenger HG, van der Meer J, van Pampus MG.

Blood Coagul Fibrinolysis. 2008 Jan;19(1):95-7. doi: 10.1097/MBC.0b013e3282f38c23.

PMID:
18180624
47.

Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.

Oosten AW, Sprenger HG, van Leeuwen JT, Meessen NE, van Assen S.

AIDS Patient Care STDS. 2008 Jan;22(1):1-6. Review.

PMID:
18095836
48.

Estimation and prediction of the HIV-AIDS-epidemic under conditions of HAART using mixtures of incubation time distributions.

Heisterkamp SH, de Vries R, Sprenger HG, Hubben GA, Postma MJ.

Stat Med. 2008 Mar 15;27(6):781-94.

PMID:
17597471
49.

Mesenteric vein thrombosis associated with primary cytomegalovirus infection: a case report.

Lijfering WM, Sprenger HG, van Son WJ, van der Meer J.

Blood Coagul Fibrinolysis. 2007 Jul;18(5):509-11.

PMID:
17581328
50.

Return of meningeal symptoms in a patient treated for cryptococcal meningitis.

Huits RM, Bremmer R, Enting RH, Sprenger HG, van Assen S.

J Neurol. 2007 Oct;254(10):1443-4. Epub 2007 Apr 2. No abstract available.

Supplemental Content

Loading ...
Support Center